Literature DB >> 17448895

VEGFR1 (Flt-1+/-) gene knockout leads to the disruption of VEGF-mediated signaling through the nitric oxide/heme oxygenase pathway in ischemic preconditioned myocardium.

Mahesh Thirunavukkarasu1, Bela Juhasz, Lijun Zhan, Venugopal P Menon, Arpad Tosaki, Hajime Otani, Nilanjana Maulik.   

Abstract

This report demonstrates that mice deficient in Flt-1 failed to establish ischemic preconditioning (PC)-mediated cardioprotection in isolated working buffer-perfused ischemic/reperfused (I/R) hearts compared to wild type (WT) subjected to the same PC protocol. WT and Flt-1+/- mice were divided into four groups: (1) WT I/R, (2) WT + PC, (3) Flt-1+/- I/R, and (4) Flt-1+/- + PC. Group 1 and 3 mice were subjected to 30 min of ischemia followed by 2 h of reperfusion and group 2 and 4 mice were subjected to four episodes of 4-min global ischemia followed by 6 min of reperfusion before ischemia/reperfusion. For both wild-type and Flt-1+/- mice, the postischemic functional recovery for the hearts was lower than the baseline, but the recovery for the knockout mice was less compared to the WT mice even in preconditioning. The myocardial infarction and apoptosis were higher in Flt-1+/- compared to wild-type I/R. Flt-1+/- KO mice demonstrated pronounced inhibition of the expression of iNOS, p-AKT & p-eNOS. Significant inhibition of STAT3 & CREB were also observed along with the inhibition of HO-1 mRNA. Results demonstrate that Flt-1+/- mouse hearts are more susceptible to ischemia/reperfusion injury and also document that preconditioning is not as effective as found in WT and therefore suggest the importance of VEGF/Flt-1 signaling in ischemic/reperfused myocardium.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17448895      PMCID: PMC1924469          DOI: 10.1016/j.freeradbiomed.2007.02.011

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  34 in total

1.  Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1/KDR activation of c-Src.

Authors:  H He; V J Venema; X Gu; R C Venema; M B Marrero; R B Caldwell
Journal:  J Biol Chem       Date:  1999-08-27       Impact factor: 5.157

2.  Expression and regulation of endothelial nitric oxide synthase.

Authors:  K Sase; T Michel
Journal:  Trends Cardiovasc Med       Date:  1997-01       Impact factor: 6.677

3.  Interaction of the Flt-1 tyrosine kinase receptor with the p85 subunit of phosphatidylinositol 3-kinase. Mapping of a novel site involved in binding.

Authors:  S A Cunningham; M N Waxham; P M Arrate; T A Brock
Journal:  J Biol Chem       Date:  1995-09-01       Impact factor: 5.157

4.  Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium.

Authors:  L Morbidelli; C H Chang; J G Douglas; H J Granger; F Ledda; M Ziche
Journal:  Am J Physiol       Date:  1996-01

5.  Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide.

Authors:  B Bussolati; C Dunk; M Grohman; C D Kontos; J Mason; A Ahmed
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

6.  Ischemic preconditioning-mediated cardioprotection is disrupted in heterozygous Flt-1 (VEGFR-1) knockout mice.

Authors:  Sankar Addya; Keisuke Shiroto; Tibor Turoczi; Lijun Zhan; Shigeaki Kaga; Shoji Fukuda; Saul Surrey; Li-Juan Duan; Guo-Hua Fong; Fumio Yamamoto; Nilanjana Maulik
Journal:  J Mol Cell Cardiol       Date:  2005-01-26       Impact factor: 5.000

7.  Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium.

Authors:  G H Fong; J Rossant; M Gertsenstein; M L Breitman
Journal:  Nature       Date:  1995-07-06       Impact factor: 49.962

8.  Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice.

Authors:  F Shalaby; J Rossant; T P Yamaguchi; M Gertsenstein; X F Wu; M L Breitman; A C Schuh
Journal:  Nature       Date:  1995-07-06       Impact factor: 49.962

9.  Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation.

Authors:  H P Gerber; A McMurtrey; J Kowalski; M Yan; B A Keyt; V Dixit; N Ferrara
Journal:  J Biol Chem       Date:  1998-11-13       Impact factor: 5.157

10.  An essential role of NFkappaB in tyrosine kinase signaling of p38 MAP kinase regulation of myocardial adaptation to ischemia.

Authors:  N Maulik; M Sato; B D Price; D K Das
Journal:  FEBS Lett       Date:  1998-06-16       Impact factor: 4.124

View more
  19 in total

1.  Thymidine phosphorylase inhibits vascular smooth muscle cell proliferation via upregulation of STAT3.

Authors:  Hong Yue; Kuniyoshi Tanaka; Tatsuhiko Furukawa; Sadashiva S Karnik; Wei Li
Journal:  Biochim Biophys Acta       Date:  2012-06-02

Review 2.  Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomes.

Authors:  Thomas Force; Kyle L Kolaja
Journal:  Nat Rev Drug Discov       Date:  2011-02       Impact factor: 84.694

Review 3.  Redox-dependent mechanisms in coronary collateral growth: the "redox window" hypothesis.

Authors:  June Yun; Petra Rocic; Yuh Fen Pung; Souad Belmadani; Ana Catarina Ribeiro Carrao; Vahagn Ohanyan; William M Chilian
Journal:  Antioxid Redox Signal       Date:  2009-08       Impact factor: 8.401

4.  VEGF165b Modulates Endothelial VEGFR1-STAT3 Signaling Pathway and Angiogenesis in Human and Experimental Peripheral Arterial Disease.

Authors:  Vijay Chaitanya Ganta; Min Choi; Anna Kutateladze; Brian H Annex
Journal:  Circ Res       Date:  2016-12-14       Impact factor: 17.367

5.  Disruption of hypoxia-inducible transcription factor-prolyl hydroxylase domain-1 (PHD-1-/-) attenuates ex vivo myocardial ischemia/reperfusion injury through hypoxia-inducible factor-1α transcription factor and its target genes in mice.

Authors:  Ram Sudheer Adluri; Mahesh Thirunavukkarasu; Nageswara Rao Dunna; Lijun Zhan; Babatunde Oriowo; Kotaro Takeda; Juan A Sanchez; Hajime Otani; Gautam Maulik; Guo-Hua Fong; Nilanjana Maulik
Journal:  Antioxid Redox Signal       Date:  2011-04-08       Impact factor: 8.401

6.  Pyrvinium, a potent small molecule Wnt inhibitor, promotes wound repair and post-MI cardiac remodeling.

Authors:  Sarika Saraswati; Maria P Alfaro; Curtis A Thorne; James Atkinson; Ethan Lee; Pampee P Young
Journal:  PLoS One       Date:  2010-11-29       Impact factor: 3.240

7.  Glycine attenuates cerebrovascular remodeling via glycine receptor alpha 2 and vascular endothelial growth factor receptor 2 after stroke.

Authors:  Zheng Chen; Xiang Wang; Haikang Liao; Tao Sheng; Panhong Chen; Hongchang Zhou; Yongliang Pan; Weiqin Liu; Hua Yao
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

8.  Signaling through the vascular endothelial growth factor receptor VEGFR-2 protects hippocampal neurons from mitochondrial dysfunction and oxidative stress.

Authors:  Tianfeng Hao; Patricia Rockwell
Journal:  Free Radic Biol Med       Date:  2013-05-31       Impact factor: 7.376

Review 9.  Precision Cardio-Oncology: a Systems-Based Perspective on Cardiotoxicity of Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors.

Authors:  Sherry-Ann Brown; Jordan C Ray; Joerg Herrmann
Journal:  J Cardiovasc Transl Res       Date:  2020-04-06       Impact factor: 4.132

10.  The Golgi apparatus is a functionally distinct Ca2+ store regulated by the PKA and Epac branches of the β1-adrenergic signaling pathway.

Authors:  Zhaokang Yang; Hannah M Kirton; David A MacDougall; John P Boyle; James Deuchars; Brenda Frater; Sreenivasan Ponnambalam; Matthew E Hardy; Edward White; Sarah C Calaghan; Chris Peers; Derek S Steele
Journal:  Sci Signal       Date:  2015-10-13       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.